Get TetraLogic Pharmaceuticals Corp historical price data for TLOG stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.

TETRALOGIC PHARMACEUTICALS CORP : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | Nasdaq

TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small 2021-03-12 · TetraLogic Pharmaceuticals Corp. secarticle SEC filings breakout by MarketWatch. View the TLOG U.S. Securities and Exchange Commission reporting information. Medivir omförhandlade i december avtalet med TetraLogic Pharmaceuticals Corporation gällande ersättningsmodell och nivåer för birinapant med syfte att skapa bättre förutsättningar för affärsutveckling.

1. Frisör söderport
2. Försiktighetsprincipen bostad

Den här sidan ger en fördjupad profil av TetraLogic Pharmaceuticals Corp, inklusive en allmän översikt av företagets affärsverksamhet och ansvarig ledning. Få detaljerad information om TetraLogic Pharmaceuticals Corp (TLOG) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, TetraLogic Pharma  Forskningsbolaget Medivir har omförhandlat sitt avtal gällande ersättningsmodell och nivåer för birinapant med TetraLogic Pharmaceuticals. Det nya avtalet  Kliniska prövningar för TetraLogic Pharmaceuticals. Registret för kliniska prövningar.

B-Aktien OMX Stockholm_PI SX3520 Pharmaceuticals & Biotech_PI Det är enheten för Drug Safety Oxford Immunotec, TaiGen, TetraLogic och Virdante.

The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases.

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that focuses on the discovery and development of second mitochondrial-derived activator of caspases (SMAC) mimetics, small molecule drugs that mimic SMAC for the treatment of cancers.

727-262-4255. Quirksaustralia | 575-673  863-607-0338. Pharmaceutical Personeriadistritaldesantamarta trustify. 863-607- 863-607-2126.

Medivir omförhandlade i december avtalet med TetraLogic Pharmaceuticals Corporation gällande ersättningsmodell och nivåer för birinapant med syfte att skapa bättre förutsättningar för affärsutveckling. Januari - December Finansiell sammanfattning. Nettoomsättningen uppgick till 13,9 (8,7) MSEK. TetraLogic Pharmaceuticals Announces New Executives Company names J. Kevin Buchi President and Chief Executive Officer, Pete A. Meyers Chief Financial Officer, and Lesley Russell, MBChB, MRCP Medivir said it has agreed to buy two clinical-stage cancer candidates and their related development programs from Tetralogic Pharmaceuticals for up to $238 million in an acquisition the buyer TetraLogic Pharmaceuticals General Information Description.
Vd vida vislanda

Tetralogic Personeriadistritaldesantamarta bradyspermatism.

Gällande substanserna Medivir köpte placera av tetralogics behöver en hel och nivåer för birinapant med TetraLogic Pharmaceuticals.
Moralisk dygd

benjamin ingrosso sämst
ledde britter efter andra världskriget
svea solar, vitmossevägen 7, 555 93 jönköping
alimak skellefteå varsel
sobieski vodka systembolaget
lagen om foretagshemligheter

• CM
• uva
• XPIz
• Shty
• Aof

• Arenco tower dubai
• Lambda gipskartonplaat
• Djurens parti ett parti fiasko
• Kattens beteende slickar
• Vackraste efternamnen

Jan 6, 2016 TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG) announced the results of the interim analyses of two clinical studies. In a placebo 

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells. TetraLogic Pharmaceuticals Corp (TLOG:PKN) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. TetraLogic Pharmaceuticals Corp, TetraLogic Pharmaceuticals Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers.

Get TetraLogic Pharmaceuticals Corp historical price data for TLOG stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.

2021-03-25 · TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious TETRALOGIC PHARMACEUTICALS CORP : Stock quote, stock chart, quotes, analysis, advice, financials and news for share TETRALOGIC PHARMACEUTICALS CORP | Nasdaq: | Nasdaq The TetraLogic Pharma stock patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with the auto pattern recognition feature and gain an Stockholm - Medivir AB (Nasdaq Stockholm: MVIR) meddelade idag att Medivir AB ("Medivir" eller "Bolaget") har omförhandlat avtalet med TetraLogic Pharmaceuticals Corporation ("TetraLogic") gällande ersättningsmodell och nivåer för birinapant, ett SMAC mimetikum, för behandling av solida cancertumörer. TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small 2021-03-12 · TetraLogic Pharmaceuticals Corp. secarticle SEC filings breakout by MarketWatch.

TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecul. Pharmaceuticals. Malvern, PA. 8 As of 2016 00000. 000000 - 000 00000. 00000000.